Discovery of a Unique Opioid Receptor That Controls Immune Cell Activation
A newly identified opioid receptor subtype (mu3) found on immune cells responds to morphine-like compounds and releases nitric oxide, revealing a direct link between opioid signaling and immune regulation.
Quick Facts
What This Study Found
The mu3 receptor on immune cells selectively binds opiate alkaloids (not endogenous opioid peptides), triggers nitric oxide release via constitutive nitric oxide synthase, and is present on macrophages, astrocytes, and leukemia cells.
Key Numbers
How They Did This
In-vitro binding studies and functional assays on macrophages, astrocytes, and HL-60 leukemia cells to characterize mu3 receptor properties, selectivity, and signaling pathways.
Why This Research Matters
Understanding how opioid receptors on immune cells work is crucial for managing the immunosuppressive effects of opioid medications and could reveal new therapeutic targets for immune modulation.
The Bigger Picture
The immune system and opioid system are deeply interconnected. The mu3 receptor provides a molecular explanation for why opioid drugs suppress immune function, which has implications for pain management, addiction medicine, and understanding immune regulation.
What This Study Doesn't Tell Us
In-vitro study using cell lines and cultured cells. The mu3 receptor's role in whole-organism immune function was not assessed. Relevance to in-vivo immune suppression by opioids needs confirmation.
Questions This Raises
- ?Could mu3-selective antagonists prevent opioid-induced immune suppression without blocking pain relief?
- ?Does chronic opioid use alter mu3 receptor expression on immune cells?
- ?Is mu3 receptor signaling involved in the immune changes seen in opioid addiction?
Trust & Context
- Key Stat:
- Alkaloid-selective Unlike classical opioid receptors, mu3 responds to morphine and codeine but not endogenous opioid peptides like endorphins
- Evidence Grade:
- Preliminary in-vitro evidence characterizing a novel receptor. Well-documented binding studies but lacks in-vivo confirmation of functional significance.
- Study Age:
- Published in 1998. The mu3 receptor concept has been debated in subsequent literature, with some aspects confirmed and others requiring further validation.
- Original Title:
- Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.
- Published In:
- Advances in experimental medicine and biology, 437, 137-48 (1998)
- Authors:
- Makman, M H, Dobrenis, K, Surratt, C K
- Database ID:
- RPEP-00475
Evidence Hierarchy
Frequently Asked Questions
Why do opioids affect the immune system?
Immune cells have opioid receptors, including the mu3 subtype described here. When opioid drugs activate these receptors, they trigger nitric oxide release that suppresses immune cell activity, potentially increasing infection risk.
Is this relevant to people taking opioid pain medications?
Yes. Understanding the mu3 receptor could eventually lead to opioid drugs that relieve pain without suppressing immunity, though that goal has not yet been achieved.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00475APA
Makman, M H; Dobrenis, K; Surratt, C K. (1998). Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.. Advances in experimental medicine and biology, 437, 137-48.
MLA
Makman, M H, et al. "Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.." Advances in experimental medicine and biology, 1998.
RethinkPeptides
RethinkPeptides Research Database. "Properties of mu 3 opiate alkaloid receptors in macrophages,..." RPEP-00475. Retrieved from https://rethinkpeptides.com/research/makman-1998-properties-of-mu-3
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.